全球首个年治疗量超千例的质子重离子中心 二期项目已在规划蓝图 在先进医疗赛道输出“中国标准”

Core Viewpoint - Proton heavy ion therapy has emerged as a powerful tool for cancer treatment, with Shanghai's Proton Heavy Ion Hospital successfully localizing and innovating treatment protocols, establishing itself as a global benchmark in particle therapy [1][2]. Group 1: Innovation and Localization - The Shanghai Proton Heavy Ion Hospital has developed a localized treatment plan suitable for Chinese cancer patients after extensive clinical research, expanding its treatment capabilities from 7 to over 50 types of cancers [2]. - The hospital has treated a total of 8,039 patients over ten years, with an annual growth rate of 17.5%, and has optimized its clinical standards to 66 items [2]. Group 2: Clinical Achievements - The hospital has achieved a five-year overall survival rate of 92.9% for nasopharyngeal carcinoma patients, with significant reductions in treatment-related side effects [3]. - It has become the first proton heavy ion center globally to exceed 1,000 treatments per year, demonstrating its capacity and commitment to high-quality care [3]. Group 3: Talent Development - The hospital has established a robust talent pipeline, training 97 master's students in radiological physics and biomedical engineering, thereby strengthening the local expertise in proton therapy [4]. - The institution is planning a second phase project to expand its facilities, aiming to become the largest particle therapy clinical center in the world [5].